CK20 mRNA expression in serum as a biomarker for colorectal cancer diagnosis: A meta-analysis

Affiliations

Ji Baoyan: Department of Oncology, Qinghai Province People’s Hospital, Xining Qinghai81000, China
Cheng Xiongfei: Department of Oncology Center, The People’s Hospital of Shiyan City HubeiProvince442000China
Cai Xiaojun: Department of Oncology Center, The People’s Hospital of Shiyan City HubeiProvince442000China
Kong Chuiyan: Department of Oncology, The People’s Hospital of Wuzhou GuangxiProvince543000, China
Yang Qingyan: Department of Oncology, The 188th Hospital of PLA, Chaozhou GuangdongProvince521000, China
Fu Ting: Department of Oncology Center, The People’s Hospital of Shiyan City HubeiProvince442000China
Wang Yahang: Department of General surgery, People’s Hospital Fenghua District Ningbo City ZhejiangProvince, 315500, PR China
Song Ying: Department of Oncology Center, The People’s Hospital of Shiyan City HubeiProvince442000China

Abstract

The aim of this study was to evaluate the diagnostic value of serumCK20 mRNA as a biomarker for colorectal cancer diagnosis by meta-analysis.